|
Hi everyone
thankyou Christine and Joe for setting this up.
I was recruited willingly for the BCIRG 006 trial after intitial diagnosis of Stage 2 HER2+++ breast cancer in November 2002 at the age of 44. Yhis international trial ( I am in Melbourne Australia) is to test the long term effectiveness of Herceptin in preventing recurrances in Her2+ patients.
I underwent a lumpectomy on 1st Dec 2002 and had one lymph node slightly pos put of 14 removed. Tumor had clean margins.
I was randomly allocated to the AC -> TH arm of the trial which entailed 4 rounds of AC followed by 4 of Taxotere with weekly herceptin and then booster 3 weekly doses of herceptin for another year.
I have completed the chemo and have had my second booster dose of herceptin and am currently undergoing radiation therapy with 11 treatments out of 30 to go.
Extemely fatigued at this point with chemo side effects still kicking in on top of the rads and looking forward to finishing the rads and allowing my body a rest.
I am er+ so will start Tamoxifen when the rads finish.
Hugs to all
Kym
|